Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT 1A /5-HT 7
作者:Zheng-Song Gu、Ai-nan Zhou、Ying Xiao、Qing-Wei Zhang、Jian-Qi Li
DOI:10.1016/j.ejmech.2017.12.063
日期:2018.1
piperazine derivatives were synthesized, and evaluated for their serotonin reuptake inhibitory and 5-HT1A/5-HT7 receptors affinities activity. Antidepressant activities in vivo of the compounds were screened using the forced swimming test (FST) and tail suspension test (TST). The results indicated that compounds 21k (RUI, IC50 = 31 nM; 5-HT1A, 5-HT7, ki = 62, 12 nM) and 21n (RUI, IC50 = 25 nM; 5-HT1A, 5-HT7
合成了一系列新型的芳烷基哌嗪衍生物,并对其5-羟色胺再摄取抑制和5-HT 1A / 5-HT 7受体亲和力活性进行了评估。使用强制游泳试验(FST)和尾部悬浮试验(TST)筛选了化合物的体内抗抑郁活性。结果表明化合物21k(RUI,IC 50 = 31 nM; 5-HT 1A,5-HT 7,k i = 62,12 nM)和21n(RUI,IC 50 = 25 nM; 5-HT 1A,5 -HT 7,K我 = 28,3.3纳米)表现出高的亲和性对5-HT 1A/ 5-HT 7受体结合有效的5-羟色胺再摄取抑制作用。具体而言,最有前途的化合物21n具有良好的口服药代动力学特性和可接受的hERG谱,并且在FST和TST模型中显示出有效的抗抑郁样作用。